STING1 and colorectal carcinoma: The combination of irinotecan dioxide nanorods and RT activates the cGAS/STING pathway in CRC, resulting in the enhanced infiltration of CD4+ T cells, CD8+ T cells, and DCs within the TME (Figure 5) (96).